Fisher-and-Paykel Healthcare Corporation is a medical instruments & supplies business based in Australia. Fisher-and-Paykel Healthcare Corporation shares (FPH) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Fisher-and-Paykel Healthcare Corporation has a trailing 12-month revenue of around $1.7 billion. If you're looking to buy shares, check out the steps below.
Our top pick for
Low costs
Our top pick for
Education & learning
Our top pick for
Australian stocks
| 52-week range | $18.426 - $25.6155 |
|---|---|
| 50-day moving average | $20.1722 |
| 200-day moving average | $22.1833 |
| Target price | $21.38 |
| PE ratio | 51.54 |
| Dividend yield | $0.41 (1.53%) |
| Earnings per share (TTM) | $0.42 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$21.72
| 1 week (2023-11-28) | 5.54% |
|---|---|
| 1 month (2023-11-03) | 7.85% |
| 3 months (2023-09-05) | 4.57% |
| 6 months (2023-06-05) | -2.16% |
| 1 year (2022-12-05) | -5.40% |
|---|---|
| 2 years (2021-12-03) | -29.50% |
| 3 years (2020-12-04) | -29.48% |
| 5 years (2018-12-05) | 83.14% |
Valuing Fisher-and-Paykel Healthcare Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Fisher-and-Paykel Healthcare Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Fisher-and-Paykel Healthcare Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 52x. In other words, Fisher-and-Paykel Healthcare Corporation shares trade at around 52x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Fisher-and-Paykel Healthcare Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.4677. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Fisher-and-Paykel Healthcare Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Fisher-and-Paykel Healthcare Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $438.4 million (£0.0 million).
The EBITDA is a measure of a Fisher-and-Paykel Healthcare Corporation's overall financial performance and is widely used to measure stock profitability.
| Revenue TTM | $1.7 billion |
|---|---|
| Operating margin TTM | 18.99% |
| Gross profit TTM | $938.4 million |
| Return on assets TTM | 9.98% |
| Return on equity TTM | 16.2% |
| Profit margin | 15.45% |
| Book value | 3.01 |
| Market capitalisation | $12.9 billion |
TTM: trailing 12 months
Dividend payout ratio: 79.61% of net profits
Recently Fisher-and-Paykel Healthcare Corporation has paid out, on average, around 79.61% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.53% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Fisher-and-Paykel Healthcare Corporation shareholders could enjoy a 1.53% return on their shares, in the form of dividend payments. In Fisher-and-Paykel Healthcare Corporation's case, that would currently equate to about A$0.41 per share.
Fisher-and-Paykel Healthcare Corporation's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 5 December 2023 (the "ex-dividend date").
Fisher-and-Paykel Healthcare Corporation's shares were split on a 5:1 basis on 27 September 2004. So if you had owned 1 share the day before the split, the next day you would own 5 shares. This wouldn't directly have changed the overall worth of your Fisher-and-Paykel Healthcare Corporation shares – just the quantity. However, indirectly, the new 80% lower share price could have impacted the market appetite for Fisher-and-Paykel Healthcare Corporation shares which in turn could have impacted Fisher-and-Paykel Healthcare Corporation's share price.
Over the last 12 months, Fisher-and-Paykel Healthcare Corporation's shares have ranged in value from as little as $18.426 up to $25.6155. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Fisher-and-Paykel Healthcare Corporation's is 0.409. This would suggest that Fisher-and-Paykel Healthcare Corporation's shares are less volatile than average (for this exchange).
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
Looking to jump on the AI bandwagon? Here's how you can invest in ChatGPT and its parent company OpenAI from Australia.
Looking for the best performing stocks in Australia? We update this list weekly.
If you’re looking for ways to gain exposure to Bitcoin and other digital currencies, cryptocurrency ETFs could be worth exploring. Find out what crypto ETFs are and how they work in this introductory guide.
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
Steps to owning and managing Microsoft shares from in Australia.
Looking for alternative investments? With a ROI of up to 3,593% lego may be worth considering. Read on to find out which lego sets are worth the investment.
Find cheap stock brokerage in Australia when buying and selling shares on the ASX and other international exchanges.
Learn about the money market and everyday consumer money market products.
Equity crowdfunding offers a unique opportunity for investors and for Australian startups, but Australia’s regulatory framework surrounding crowdfunding still lags behind the rest of the world.
Follow these tips to find the best share trading platform for you.
